Figure 2.
Incidence of ≥Gr3 NC AEs based on the characteristics of CRS. (A) Dot plot of ≥Gr3 NC AEs in patients based on the presence of CRS. (B) Dot plot of ≥Gr3 NC AEs in patients based on severity of CRS maximum grade 1 or 2 vs 3 or 4 as graded per American Society for Transplantation and Cellular Therapy guidelines. (C) Pie graph of ≥Gr3 NC AEs in patients with CRS based on the system. (D) Pie graph of ≥Gr3 NC AEs in patients without CRS based on the system. (E) Timing of ≥Gr3 NC AEs in patients with CRS separated based on the percentage, with onset before (before CRS, red) or after (after CRS, blue) the onset of CRS.